280 related articles for article (PubMed ID: 35321968)
1. Hypertrophic Pachymeningitis Development in Eosinophilic Granulomatosis with Polyangiitis at Relapse of Disease: A Case-Based Review.
Kiyohara M; Shirai T; Nishiyama S; Sato H; Fujii H; Ishii T; Harigae H
Tohoku J Exp Med; 2022 Mar; 256(3):241-247. PubMed ID: 35321968
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic pachymeningitis in eosinophilic granulomatosis with polyangiitis.
Izuka S; Yamashita H; Takahashi Y; Kaneko H
Mod Rheumatol Case Rep; 2022 Jan; 6(1):80-82. PubMed ID: 34480185
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic Pachymeningitis with Characteristics of Both IgG4-related Disorders and Granulomatosis with Polyangiitis.
Mori M; Sakai K; Saito K; Nojima T; Mohri M; Matsubara K; Hayashi S; Yamada M
Intern Med; 2022 Jun; 61(12):1903-1906. PubMed ID: 34803104
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Shimojima Y; Kishida D; Hineno A; Yazaki M; Sekijima Y; Ikeda SI
Int J Rheum Dis; 2017 Apr; 20(4):489-496. PubMed ID: 28217942
[TBL] [Abstract][Full Text] [Related]
6. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
Shimojima Y; Sekijima Y
Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
[TBL] [Abstract][Full Text] [Related]
8. Pathological findings of hypertrophic pachymeningitis associated with eosinophilic granulomatosis with polyangiitis.
Shiraishi W; Tsujimoto Y; Shiraishi T
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34544704
[TBL] [Abstract][Full Text] [Related]
9. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.
Choi HA; Lee MJ; Chung CS
J Neurol; 2017 Apr; 264(4):724-732. PubMed ID: 28220286
[TBL] [Abstract][Full Text] [Related]
11. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
[TBL] [Abstract][Full Text] [Related]
12. A challenging diagnosis of MPO-C-ANCA EGPA.
Lim G; Lim S; Tee SI; Ling CY
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31296634
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophic Pachymeningitis as a Delayed Complication of Granulomatosis with Polyangiitis.
Kumamoto M; Tomoda K; Furuya Y; Iwasa N; Ueno S; Yoshikawa M; Kimura H
Intern Med; 2016; 55(4):413-7. PubMed ID: 26875970
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids.
Mattsson G; Magnusson P
BMC Cardiovasc Disord; 2017 Dec; 17(1):299. PubMed ID: 29262787
[TBL] [Abstract][Full Text] [Related]
15. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
16. Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Papo M; Sinico RA; Teixeira V; Venhoff N; Urban ML; Iudici M; Mahrhold J; Locatelli F; Cassone G; Schiavon F; Seeliger B; Neumann T; Kroegel C; Groh M; Marvisi C; Samson M; Barba T; Jayne D; Troilo A; Thiel J; Hellmich B; Monti S; Montecucco C; Salvarani C; Kahn JE; Bonnotte B; Durel CA; Puéchal X; Mouthon L; Guillevin L; Emmi G; Vaglio A; Terrier B;
Rheumatology (Oxford); 2021 Sep; 60(9):4355-4360. PubMed ID: 33347592
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Middle lobe syndrome: a rare presentation in eosinophilic granulomatosis with polyangiitis.
Maranini B; Guzzinati I; Casoni GL; Ballotta M; Lo Monaco A; Govoni M
Front Immunol; 2023; 14():1222431. PubMed ID: 37638004
[TBL] [Abstract][Full Text] [Related]
18. Relationship among antineutrophil cytoplasmic antibody, blood urea nitrogen and complement in patients with eosinophilic granulomatosis polyangiitis (Churg-Strauss syndrome).
Kawakami T; Kimura S; Takeuchi S; Soma Y
J Dermatol; 2013 Jul; 40(7):511-5. PubMed ID: 23594281
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort.
Liu S; Han L; Liu Y; Yang J; Zhang Y; Li M; Tian X; Zeng X; Wang L; Zhang F
Front Immunol; 2022; 13():885198. PubMed ID: 35833130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
